Physician profile
Mihae Yu
NPI 1891738944
$37,188.36
in general payments reported to CMS, 2019-2025
15 companies · $1,661 in 2025
The $1,661 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $4,031 · 2021: $10K · 2022: $15K · 2023: $4,598 · 2024: $405 · 2025: $1,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,992 · Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,992.16 |
| Food and Beverage | $1,671.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,548.07 | 2019-2025 | |
| Medtronic, INC. | $4,361.92 | 2023-2025 | Signia, Ligasure |
| Davol INC. | $1,539.22 | 2020-2025 | Phasix Mesh |
| Conmed Corporation | $810.33 | 2021-2022 | |
| Abbvie INC. | $238.30 | 2021-2025 | Dalvance |
| Axogen | $164.32 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Abbott Laboratories | $110.40 | 2023 | Absolute Pro |
| Pfizer INC. | $89.75 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $76.95 | 2019 | |
| Ethicon US, LLC | $68.41 | 2024-2025 | Stratafix, Ethicon, Surgiflo Hemostatic Matrix |
| Biomerieux INC | $65.38 | 2023 | Nephrocheck Liquid Control Kit |
| Astrazeneca Pharmaceuticals LP | $39.19 | 2023 | Andexxa |
| Convatec INC. | $37.99 | 2019 | |
| Becton, Dickinson and Company | $24.02 | 2024 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $14.11 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihae Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.